Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update-Reference-Cited by-同舟云学术

Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update

Published:2021-05-01 Issue:6 Volume:23 Page:
ISSN:1523-3774
Container-title:Current Rheumatology Reports
language:en
Short-container-title:Curr Rheumatol Rep

Author:

Erkan Doruk^ORCID,Sciascia Savino,Bertolaccini Maria Laura,Cohen Hannah,Andrade Danieli,Atsumi Tatsuya,Gerosa Maria,Petri Michelle,Roubey Robert,Tektonidou Maria,

Publisher

Springer Science and Business Media LLC

Subject

Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s11926-021-01008-8.pdf

Reference58 articles.

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome. J Thromb Haemost. 2006;4(2):295–306.

2. Erkan D, Derksen R, Levy R, Machin S, Ortel T, Pierangeli S, et al. Antiphospholipid syndrome clinical research task force report. Lupus. 2011;20(2):219–24.

3. Erkan D, Lockshin MD, APS ACTION members. APS ACTION-AntiPhospholipid Syndrome Alliance for clinical trials and international networking. Lupus. 2012;21(7):695–8.

4. Duarte-García A, Pham MM, Crowson CS, Amin S, Moder KG, Pruthi RK, et al. The epidemiology of antiphospholipid syndrome: a population-based study. Arthritis Rheum. 2019;71(9):1545–52.

5. Radin M, Sciascia S, Bazzan M, Bertero T, Carignola R, Montabone E, et al. Antiphospholipid syndrome is still a rare disease-estimated prevalence in the Piedmont and Aosta Valley regions of Northwest Italy: comment on the article by Duarte-García et al. Arthritis Rheum. 2020;72(10):1774–6.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiphospholipid-Syndrom: neue Klassifikationskriterien und Implikationen für die Praxis;Aktuelle Rheumatologie;2024-04-17

2. Testing for the lupus anticoagulant: the good, the bad, and the ugly;Research and Practice in Thrombosis and Haemostasis;2024-03

3. Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic;Rheumatology International;2024-02-23

4. Antibodies to Neutrophil Extracellular Traps: Novel Markers for the Antiphospholipid Syndrome;Arthritis & Rheumatology;2023-06-22

5. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study;Laboratory Investigation;2023-06